Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from AmerisourceBergen

Drug Distributor Cencora Falls; Blame Walgreens, Not The Supreme Court

Cencora stock and other drug distributors fell on Wednesday, hit by Walgreens results, not the ruling that killed an opioid settlement.

Investors Business Daily

Chart of the Day: AmerisourceBergen - Healthcare Giant

The Chart of the Day belongs to the healthcare company AmerisourceBergen (ABC) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

Barchart

IBD Stock Of The Day: Why McKesson And Its Rivals Are 'So Hot' Right Now

McKesson is Wednesday's IBD Stock Of The Day. Drug distributors are hot and MCK stock is consolidating following a strong quarterly report.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

AmerisourceBergen Stock Joins Elite Group Of Top Performers

AmerisourceBergen sees its Relative Strength Rating move into the 80-plus level.

Investors Business Daily

‘Too many are dying’; drug companies’ opioid settlement to help Chicago aid drug users

Heather O’Donnell of the Chicago social services agency Thresholds says the money is “an opportunity to really build up substance use care.”

Chicago Sun-Times

Recession Coming? Don't Ask This Hot Fund's Managers

Want to know what the market will do in 2023? Is a recession coming? Don't ask EIC Value Fund's managers even though they're slaying the broad market.

Investors Business Daily

Feds sue drug wholesaler AmerisourceBergen over opioid sales

The U.S. Justice Department is alleging that a major drug wholesaler contributed to the deadly toll from opioids by turning a blind eye to warning signs about suspicious sales to its pharmacy customers

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Feds sue AmerisourceBergen over 'hundreds of thousands' of alleged opioid violations

DOJ officials say the drug wholesaler could face "billions of dollars" in penalties for failing to report diversion of prescription opioid pain medications shipped to pharmacies across the U.S.

WEKU

IBD Stock Of The Day Cardinal Health Hurdles A Board Shake-Up To Outperform

Cardinal Health is the IBD Stock Of The Day as a drug distribution rally sends CAH stock within striking distance of two potential entries.

Investors Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022

Upgrades

Benzinga

Stock Market Rally Mixed As Oil Prices Fall, Job Growth Hot: Weekly Review

The stock market rally had mixed action, with the Nasdaq and small caps rising while the S&P 500 and oil prices fell.

Investors Business Daily

WVa cities, counties reach $400M settlement with drug firms

West Virginia cities and counties have reached a $400 million tentative settlement with three major U.S. drug distributors

The Independent UK

IBD Stock Of The Day McKesson Leads Wholesaler Rally, Nears A Breakout

McKesson is the IBD Stock Of The Day. A drug wholesaler rally is sending McKesson stock near a breakout. Rivals are also on the rise.

Investors Business Daily

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $3,800 Today

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 10 years by 2.86% on an annualized basis producing an average annual return of 14.13%. Currently, AmerisourceBergen has a market capitalization of $30.43 billion.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Where AmerisourceBergen Stands With Analysts

Analysts have provided the following ratings for AmerisourceBergen (NYSE:ABC) within the last quarter:

Benzinga

$100 Invested In This Stock 20 Years Ago Would Be Worth $700 Today

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 20 years by 3.28% on an annualized basis producing an average annual return of 10.4%. Currently, AmerisourceBergen has a market capitalization of $30.65 billion.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022

Upgrades

Benzinga

Here's How Much You Would Have Made Owning AmerisourceBergen Stock In The Last 20 Years

AmerisourceBergen (NYSE:ABC) has outperformed the market over the past 20 years by 3.71% on an annualized basis producing an average annual return of 10.86%. Currently, AmerisourceBergen has a market capitalization of $32.37 billion.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Analyst Ratings for AmerisourceBergen

Within the last quarter, AmerisourceBergen (NYSE:ABC) has observed the following analyst ratings:

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga

AmerisourceBergen Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q2, AmerisourceBergen (NYSE:ABC) earned $555.25 million, a 23.55% increase from the preceding quarter. AmerisourceBergen's sales decreased to $57.72 billion, a 3.2% change since Q1.

Benzinga

Moderna And 3 Other Stocks Insiders Are Selling

US crude oil futures traded lower, dropping around 0.5% on Monday. Investors, meanwhile, focused on some notable insider trades.

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

The Independent UK

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

Investors Business Daily

Stock Market Dips As Another Inflation Gauge Rises; Tech And Utilities Lead Declines; Disney Takes A Hit

The stock market dipped Thursday as wholesale inflation rose and Disney took an earnings hit. Retailers led gainers.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.